By Biolink Life Sciences
Now Live Phosveda® BioLink Life Sciences is pleased to announce the launch of our product website for Phosveda®, our patented calcium succinate targeted for the treatment of hyperphosphatemia in End Stage Renal Disease (ESRD) patients.
By Rubix LS
Rubix LS Isolated Protein Binding Receptors in Ebola and Leishmaniasis Providing Rapid Spectral Analysis of Key Proteins in Real Time Its Technology Now Being Fit to Target Coronavirus
By Biolink Life Sciences
BioLink Life Sciences is pleased to announce that it recently had its patent application allowed by the USPTO for the composition, use and formulation of Strontium SR.
By MJO Publications
Contemporary Science Fiction Author Matthew J Opdyke recently released the final six parts of his space opera series, currently available on Amazon in eBook and paperback formats.
By NOUS Imaging
Software designed to eliminate safety risks and billions of dollars in wasted costs
By Church of Perpetual Life
Perpetual Life hosts monthly science-based services. Every 4th Thursday of the Month. Doors Open 6 pm - 12 am. This month's guest speaker is Dr. Duncan Ross, founder of Kimera Labs, Inc. He will be speaking about Exosome Therapy and Regenerative Medicine.
By Theravest Management
Scientists today now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead our body and brain to decline as we age.
By Vitality in Aging (VIA) Research Group
New public benefit research organization, Vitality in Aging (VIA) Research Group, announces its launch with ground-breaking Longitudinal Study and Interventions Trial at RAADfest conference held at Westgate Las Vegas Resort & Casino, Las Vegas, Nevada.
By Author Matthew J. Opdyke
Author Matthew J. Opdyke's First Anniversary eBook will be released just around the corner! His paperback and hardcover versions are out now!!!
By Oncoheroes Biosciences Inc.
Oncoheroes Biosciences Inc. ("Oncoheroes") and Boehringer Ingelheim International GmbH ("Boehringer Ingelheim") have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered..
By Theravest Management
Deciding when to invest in a biotechnology company Often investors we meet are not sure when to invest in a biotechnology company.
By ResoTher Pharma ApS
A Danish biotech believe they have a novel therapy that will protect the heart in the critical days after myocardial infarction, reducing heart failure and improving patient´s lives.
By ReStem Biotech
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, spinal cord injury and cancer, sponsored the Guangdong Private..
By Golden Helix
Automated and Guided Workflows for Clinical Testing Using NGS Assays
By LGM Pharma
Orphanion AG, a CRO/CMO that focuses on contract research and manufacturing services for niche active pharmaceutical ingredients (APIs), and LGM Pharma, LLC, a leader in API sourcing, warehousing and distribution services to the pharmaceutical and...
By European Society of Cardiology
Don't ignore heart attack symptoms while traveling, keep emergency numbers at hand.That's the main message of a new study. Cardiovascular disease is the leading cause of natural death among people who are traveling, yet, so far, the long-term outlook
By Neurolixis, Inc.
A new article in the Journal of Medicinal Chemistry describes the characterization of novel selective serotonin 5-HT1A receptor biased agonists.
S-cubed is pleased to announce that after a rigorous evaluation process, the Qlik development team have been awarded Specialization Status in the Pharmaceutical and Biotech Industries.
By Bioquark Inc.
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe.
By TRIGR Therapeutics
TRIGR Therapeutics, Inc. ("TRIGR"), a privately held biotechnology company focused on the clinical development and commercialization of bispecific antibody therapeutics for oncology and ophthalmology indications, announced that it will present at Biotech.
Novodiax Inc., a leader in intraoperative immunohistochemistry (IHC) technology, announces the availability of two new ihcDirect staining kits for in vitro diagnostic (IVD) use: CD20 and Vimentin.
By AmerAsia Report
AmerAsia Report, a leading provider of education and information across the America's and Asia, today published an update to an astounding year's long precedent of getting trapped inside the honey pot.
Ever Innovating, Stemology® Announces the Release of SRC-7™, Its Patent-Pending Advanced Stem Cell Technology Complex
By Keystone Symposia
Keystone Symposia, in partnership with Vienna BioCenter Research Institutes GMI, IMBA, IMP and MFPL, is pleased to announce a series of scientific research conferences to be held at Vienna BioCenter in Vienna, Austria.
By R3eWaste, Sonora Quest Laboratories
Two Phoenix-based companies working together to help each other and the environment.
Sophie Schmitz, Managing Partner of Partners4Access is to chair a panel discussion on rare diseases at the BioIndustry Association or BIA's event UK Bioscience Forum on October 18, 2018.
By Wareham Development
Newly Constructed Research Campus in Emeryville, Now Leasing
By Golden Helix, Inc.
Integrating CNV analysis into a NextGen sequencing clinical analytics platform
By Pharma Market Research Conference
Switzerland will host anticipated assembly of market research influencers
· New combination reduces blocked nose without a pharmaceutical ingredient while simultaneously combating viral airway infections · Patent application submitted for innovative formulation Vienna, 7 August 2018.
By RGR Medical Products Inc
David Carter was hired as Vice President of retail accounts for RGR medical and in charge of promoting SleepEeze. Carter a 20 year veteran of retail sales, comes to RGR Medical from the successful sale of his own private business in 2016